We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byBrooke Gallegos
Modified over 2 years ago
Saurabh Aggarwal, 1 Christine M. Gross, 1 Shruti Sharma, 1 Jeffrey R. Fineman, 2,3 and Stephen M. Black *1 Compr Physiol DOI: /cphy. C Copyright © 2013 American Physiological Society Figure 1 Schematic view of the pathology of pulmonary hypertension (PH). The figure summarizes the major pathological events that lead to the development of PH. In humans, PH is a complex and multifactorial, diffuse disorder of the pulmonary vasculature. However, for the purposes of research and inducing PH in animal models, the etiology of PH can be broadly distinguished into: (A) inflammatory; (B) high shear stress; and (C) hypoxia, even though none of these factors act alone during the progression of the disease. A common mechanism by which these insults provoke vascular dysfunction is by either increasing the production of reactive oxygen species (ROS) or by attenuating the ROS scavenging capability of the cells. Once produced, ROS can influence the growth and morphology of all three layers of the pulmonary vessels. In endothelial cells, ROS promote endothelial proliferation, decrease NO production, and increase the release of vasoactive mediators, leading to endothelial dysfunction. In smooth muscle cells (SMC), oxidative stress caused by ROS induces contraction and a switch to a synthetic phenotype. These SMC alterations are brought about by increasing the intracellular free Ca 2+ and decreasing the expression of contractile phenotypic markers, while simultaneously enhancing the expression of proliferative phenotypic markers and growth factors. ROS can also augment the proliferation of fibroblasts in the adventitial layer and their expansion between the endothelium and the internal elastic lamina, known as the neointima (not depicted in the figure). Together, these changes result in vascular remodeling and the development of PH.
Saurabh Aggarwal, 1 Christine M. Gross, 1 Shruti Sharma, 1 Jeffrey R. Fineman, 2,3 and Stephen M. Black *1 Compr Physiol DOI: /cphy. C Copyright © 2013 American Physiological Society Figure 2 Reactive oxygen species (ROS) generation in pulmonary hypertension. The major sources of ROS in the vasculature include uncoupled endothelial nitric oxide synthase (eNOS), mitochondrial dysfunction, NADPH oxidase, and xanthine oxidase (XO). In pulmonary hypertension (PH), all of these sources contribute to the development of oxidative stress. eNOS uncoupling is mediated by limited L-arginine availability, as a result of increased degradation by arginase upregulation and attenuated synthesis by the downregulation of argininosuccinate synthetase (ASS) and argininosuccinate lyase (ASL), the enzymes responsible for the conversion of L-citrulline to L-arginine. Moreover, a sustained increase in asymmetric dimethyl-l-arginine (ADMA) levels, due to a decrease in dimethylarginine dimethylaminohydrolase 2 (DDAH2) activity, competes with L-arginine for binding to eNOS. In addition, in PH, eNOS function is impaired by a decrease in BH 4, an essential cofactor for NO generation. GTP cyclohydrolase I (GCH1), the rate-limiting enzyme in BH 4 biosynthesis, is ubiquinated and targeted for degradation by Hsp70/CHIP. Therefore, the low GCH1 levels, limit the production of BH 4. Finally, the disruption of the zinc tetrathiolate (ZnS 4 ) cluster by oxidative attack disrupts the eNOS dimer, which is accompanied by decreased NO generation and increased ROS production. Further, in PH, several markers of mitochondrial dysfunction are observed, including increased levels of uncoupling protein-2 (UCP-2), decreased levels of the mitochondrial antioxidant, superoxide dismutase-2 (SOD2), and the impaired function of complexes I, II, and III of the respiratory chain. Interestingly, ADMA appears to promote these changes in the mitochondria, and also augment mitochondrial ROS generation and decrease ATP production. In addition, several subunits of NADPH oxidase, including p47 phox, p67phox, gp91phox, and Rac1, are upregulated in PH, increasing ROS production in the vasculature. Increased levels and activity of XO also contribute to oxidative stress and vascular dysfunction in the early stages of PH.
Saurabh Aggarwal, 1 Christine M. Gross, 1 Shruti Sharma, 1 Jeffrey R. Fineman, 2,3 and Stephen M. Black *1 Compr Physiol DOI: /cphy. C Copyright © 2013 American Physiological Society Figure 3 Reactive oxygen species (ROS) signaling in pulmonary hypertension. The vasoactive mediators that contribute to the development of pulmonary vascular remodeling and pulmonary hypertension (PH) can be broadly divided into two major categories: factors affecting vascular tone and factors influencing vessel wall thickening. ROS influence the generation of several of these factors. In PH, ROS decrease the expression and/or function of redox sensitive voltage gated K + channels (Kv1.5 and Kv2.1), leading to elevations in intracellular K + and Ca 2+ influx through the activation of voltage-gated L-type Ca 2+ channels. In turn, Ca 2+ induces smooth muscle cell (SMC) contraction through the calmodulin-dependent activation of myosin light chain kinase (MLCK) and the subsequent phosphorylation of the myosin light chain (MLC). ROS also promote the activation of the small GTPase, RhoA, and its downstream effector, Rho kinase, which increase the phosphorylation of MLC through the inhibition of MLC phosphatase. In addition, ROS promote pulmonary vessel constriction by enhancing the production of endothelin-1 (ET-1) and thromboxane A2 (TXA2), while attenuating the levels of vasodilators, such as prostacyclin and peroxisome proliferator-activated receptors- (PPAR- ). The role of ROS in mediating pulmonary SMC proliferation and vessel thickening is more complex. Oxidative stress induces the expression of several growth factors, such as transforming growth factor- 1 (TGF- 1), vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), and platelet-derived growth factor (PDGF). In addition, ROS also activate p38MAPK and ERK1/2, which promote proliferation. The MAPK signaling pathway is also activated by pp60 Src, through ROSmediated activation. Further, ROS stimulate Akt1, which promotes SMC proliferation through the upregulation of PGC-1. Together, the dysregulation of these constrictive and proliferative factors by ROS promotes the vascular remodeling seen in PH.
Saurabh Aggarwal, 1 Christine M. Gross, 1 Shruti Sharma, 1 Jeffrey R. Fineman, 2,3 and Stephen M. Black *1 Compr Physiol DOI: /cphy. C Copyright © 2013 American Physiological Society Figure 4 Reactive oxygen species (ROS) scavenging in pulmonary hypertension. ROS are scavenged by antioxidant systems to preserve the cellular redox homeostasis and to prevent oxidative damage to cellular proteins, lipids, and DNA. The major vascular enzymatic antioxidants are superoxide dismutase (SOD), catalase, and GPx. There are three types of SOD: cytoplasmic Cu/ZnSOD (SOD1), mitochondrial MnSOD (SOD2), and extracellular EC-SOD (SOD3) that catalyze the rapid conversion of O 2 – into H 2 O 2. In PH, there is a decrease in the expression and/or activity of all three SOD isoforms, increasing O 2 – levels. The H 2 O 2 that is produced by SOD can be enzymatically reduced in the cytoplasm by catalase and GPx. Catalase decomposes H 2 O 2 to O 2 and H 2 O, while GPx requires two molecules of glutathione (GSH) to reduce one molecule of H 2 O 2 to two molecules of H 2 O and in the process GSH is oxidized to glutathione disulfide (GSSG). Catalase activity/expression is altered in PH, while the expression/activity of GPx is decreased in many forms of PH. The result of reduced ROS quenching by these antioxidants adds to the oxidative stress observed in PH.
Metabolism. Metabolism is the set of life-sustaining chemical transformations within the cells of living organisms. These enzyme- catalyzed reactions.
Chapter 1 PART I: Essential Pathology - Mechanisms of Disease Molecular Mechanisms of Cell Death Companion site for Molecular Pathology Author: William.
1 Chapter 22 Cyclic Nucleotides in the Nervous System Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
BIO 402/502 Advanced Cell & Developmental Biology I Section I: Dr. Berezney.
Cell Communication Cells need to communicate with one another, whether they are located close to each other or far apart. Extracellular signaling molecules.
1 Chapter 25 Serine and Threonine Phosphorylation Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
1 Chapter 26 Tyrosine Phosphorylation Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
Chemical Carcinogenesis: Initiation, Promotion and Progression NST110, Toxicology Department of Nutritional Sciences and Toxicology University of California,
Leicester Warwick Medical School Cellular Adaptations Dr Gerald Saldanha Department of Pathology
Plant Response to Stress BC39P- Plant Biochemistry Dr. W. McLaughlin.
Writing the Manuscript: Discussion & Introduction APS Professional Skills Course: Writing and Reviewing for Scientific Journals.
1 Chapter 36 Lipid Mediators: Eicosanoids, Docosanoids and Platelet-Activating Factor Copyright © 2012, American Society for Neurochemistry. Published.
G Protein Linked Receptors. Introduction G-protein-linked receptors are the largest family of cell-surface receptors. More than 100 members have already.
Chapter 3 Chapter 3 Synthesis, Metabolism, and Actions of Bioregulators Copyright © 2013 Elsevier Inc. All rights reserved.
1 Chapter 37 Apoptosis and Necrosis Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
Lecture #9. July 13,2001 Cell signaling: Receptor tyrosine kinases NO and NYC. Chapter 15. Axiom #9: Multitasking is essential for success.
1 Chapter 7 Intracellular Trafficking Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
Chapter 9 Intracellular Signaling Copyright © 2014 Elsevier Inc. All rights reserved.
The Cellular Internet Cell-to-cell communication is essential for multicellular organisms Biologists have discovered some universal mechanisms of cellular.
Nitric oxide…Neurotransmitter? B.Sc EDRF: endothelium-derived relaxing factor Furchgott in 1980 showed that Acetylcholine-stimulated relaxation.
ATP as a Signaling Molecule. CONTENTS What is ATP..? ATP as a Signaling Molecule ATP Storage and Release Purinergic Receptors ATP in Extracellular Signaling.
April 2005 Ark International Training Seminars Cytokine : Hormone interrelationship R A Holding DO.
Chapter 25: Metabolism. Introduction to Cellular Metabolism Figure 25–1 Formation of Organic Molecules Energy production begins in cytosol Energy is captured.
1 Chapter 60 Neurobiology of Severe Mood and Anxiety Disorders Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights.
Cattedra di Cardiochirurgia UNIVERSITA DEGLI STUDI DI FIRENZE Terapia chirurgica della cardiopatia ischemica Anatomia e fisiopatologia del circolo coronarico.
The food we eat is our only source of energy for performing biological work. There are three major metabolic destinations for the principle nutrients.
Drugs Used in Coagulation Disorder Anticoagulant Drugs Fibrolytic Drugs Antithrombotic / Antiplatelet Drugs.
T Cell Receptor & T Cell Development. 2 Questions for the next 2 lectures : How do you generate a diverse T cell population with functional TCR rearrangements?
CHAPTER 12 THE CELL CYCLE Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section C: Regulation of the Cell Cycle 1.A molecular.
© 2013 Pearson Education, Inc. Endocrine System: Overview Acts with nervous system to coordinate and integrate activity of body cells Influences metabolic.
© 2016 SlidePlayer.com Inc. All rights reserved.